Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June 30, 2013.
For the 2013 second quarter, the company reported net sales of $11.5 million, versus $14.9 million in the prior-year period. IntriCon had a net loss of $(3.4) million, or $(0.60) per diluted share, compared to a net loss of $(82,000), or $(0.01) per diluted share, for the 2012 second quarter.
Hey, check out all the engineering jobs. Post your resume today!
